MrMed is an online pharmacy for super-specialty medicines based in India. It was founded by Devashish Singh and Saurab Jain and has its headquarters in Chennai. In 2022, the company received an award from the Government of Tamil Nadu for its contributions to healthcare.
MrMed was conceived in August 2020 when Devashish Singh and Saurab Jain noticed challenges in specialty medicines. Despite facing initial setbacks due to the COVID Delta wave in India, which prompted the founders and their team to prioritize community assistance, MrMed was officially launched in June 2021. The company launched its mobile app in March 2023 for access to speciality medicines for conditions such as cancer, transplants, kidney, or liver diseases. It also raised $500,000 in funding from the Tamil Nadu Emerging Sector Seed Fund (TNESSF) and angel investors.
On 8 December 2025, the company announced a strategic partnership with the American multinational pharmaceutical company Eli Lilly to support the distribution of specialty medicines in India.
MrMed's headquarters are in Chennai, with dispatch hubs located in Delhi and Bangalore. According to the Economic Times, the company reported an Annual Recurring Revenue (ARR) of â¹26 crore. In April 2024, the company entered the offline retail segment with the opening of its first store in Chennai.
In 2022, MrMed was awarded the Health Care Start-up Of The Year by the Federation of Indian Chambers of Commerce and Industry (FICCI) in Chennai, presented by Ma. Subramanian, the Minister for Health and Family Welfare, Government of Tamil Nadu.